Earnings History Data for SCYNEXIS (SCYX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

SCYNEXIS

SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM		SCYX	SCYNEXIS	50.00	-0.06	-0.20	0.00	SCYNEXIS GAAP EPS of -$0.06, revenue of $0.66M [11/7/2024 2:38 AM]	1.34	0.02 (1.89%)	1.31	-0.01 (-0.76%)	1.26 - 3.07	142,904	140,000	2,956
SCYNEXIS GAAP EPS of -$0.06, revenue of $0.66M [11/7/2024 2:38 AM]
08-08-2024	AH		SCYX	SCYNEXIS	73.00	-0.30	-0.19	0.00	SCYNEXIS GAAP EPS of -$0.30 misses by $0.10 [8/8/2024 6:05 PM]	1.75	-0.16 (-8.12%)	1.85	-0.06 (-3.14%)	1.35 - 3.87	139,002	120,000	756
SCYNEXIS GAAP EPS of -$0.30 misses by $0.10 [8/8/2024 6:05 PM]
08-05-2024	AH		SCYX	SCYNEXIS	65.00	-0.15	-0.18	0.00	SCYNEXIS GAAP EPS of $0.01 beats by $0.20, revenue of $1.37M beats by $1.07M [5/8/2024 5:40 PM]	1.86	0.02 (1.18%)	1.94	0.10 (5.43%)	1.35 - 3.87	131,092	180,000	5,219
SCYNEXIS GAAP EPS of $0.01 beats by $0.20, revenue of $1.37M beats by $1.07M [5/8/2024 5:40 PM]
28-03-2024	AH		SCYX	SCYNEXIS	52.00	-0.39	0.31	0.00	SCYNEXIS GAAP EPS of $1.39 misses by $0.14, revenue of $140.14M misses by $1.84M [3/28/2024 4:59 PM]	1.47	0.04 (3.16%)	1.51	0.04 (2.72%)	1.35 - 3.87	179,175	250,000	4,711
SCYNEXIS GAAP EPS of $1.39 misses by $0.14, revenue of $140.14M misses by $1.84M [3/28/2024 4:59 PM]
13-11-2023	AH		SCYX	SCYNEXIS	63.00	-0.04	0.29	0.00	SCYNEXIS GAAP EPS of -$0.04, revenue of $1.8M [11/14/2023 10:18 AM]	1.71	-0.01 (-0.29%)	1.77	0.05 (3.20%)	1.15 - 3.87	203,663	190,000	5,345
SCYNEXIS files to sell 32.5M shares [11/13/2023 5:13 PM] SCYNEXIS GAAP EPS of -$0.04, revenue of $1.8M [11/14/2023 10:18 AM]
14-08-2023	AH		SCYX	SCYNEXIS	109.00	2.46	1.03	0.00	SCYNEXIS GAAP EPS of $2.46 beats by $1.01, revenue of $131.5M beats by $36.1M [8/14/2023 5:39 PM]	2.77	-0.03 (-1.07%)	3.25	0.45 (16.07%)	1.15 - 3.84	2,178,035	140,000	1,450,579
SCYNEXIS GAAP EPS of $2.46 beats by $1.01, revenue of $131.5M beats by $36.1M [8/14/2023 5:39 PM]
31-03-2023	PM		SCYX	SCYNEXIS	55.00	-0.29	-0.50	0.00	SCYNEXIS GAAP EPS of -$0.30 beats by $0.10, revenue of $1.4M beats by $0.13M [3/31/2023 8:39 AM]	3.00	0.06 (2.21%)	3.02	0.08 (2.72%)	1.15 - 4.04	8,631,629	7,320,000	889,596
SCYNEXIS GAAP EPS of -$0.30 beats by $0.10, revenue of $1.4M beats by $0.13M [3/31/2023 8:39 AM] SCYNEXIS jumps 92% on licensing deal with GSK for anti-fungal agent [3/30/2023 7:40 AM]
09-11-2022	PM	7:00 AM ET (Nov 9)	SCYX	SCYNEXIS, Inc.	72.81	-0.62	-0.51	-0.06	SCYNEXIS GAAP EPS of -$0.62 misses by $0.12, revenue of $1.56M misses by $0.5M [11/9/2022 7:07 AM]	1.80	-0.44 (-19.64%)	2.12	-0.12 (-5.36%)	1.70 - 8.10	367,637	100,000	2,624
SCYNEXIS GAAP EPS of -$0.62 misses by $0.12, revenue of $1.56M misses by $0.5M [11/9/2022 7:07 AM] SCYNEXIS Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-09-22 07:00AM]
15-08-2022	PM	7:00 AM ET (Aug 15)	SCYX	SCYNEXIS, Inc.	71.35	-0.53	-0.56	-0.22	SCYNEXIS GAAP EPS of -$0.31 beats by $0.28, revenue of $1.32M misses by $0.32M [8/15/2022 7:05 AM]	2.94	0.07 (2.44%)	2.90	0.03 (1.05%)	1.70 - 8.10	167,539	150,000	4,558
SCYNEXIS GAAP EPS of -$0.31 beats by $0.28, revenue of $1.32M misses by $0.32M [8/15/2022 7:05 AM] Scynexis stock rises as Brexafemme sales nearly double Q/Q [8/15/2022 12:47 PM] SCYNEXIS Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-15-22 07:00AM]
12-05-2022	PM	7:00 AM ET (May 12)	SCYX	SCYNEXIS, Inc.	57.86	-0.51	-0.74	-0.23	SCYNEXIS GAAP EPS of -$0.17, revenue of $0.7M [5/12/2022 7:02 AM]	1.87	0.0 (0.00%)	1.89	0.02 (1.07%)	1.81 - 10.25	268,446	300,000	1,181
SCYNEXIS Q1 2022 Earnings Preview [5/11/2022 1:22 PM] SCYNEXIS GAAP EPS of -$0.17, revenue of $0.7M [5/12/2022 7:02 AM] SCYNEXIS Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 07:00AM] Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates [May-12-22 08:35AM]
29-03-2022	PM	7:35 AM ET (Mar 29)	SCYX	SCYNEXIS, Inc.	115.44	-1.05	-0.71	-1.47	SCYNEXIS GAAP EPS of -$1.05 misses by $0.28, revenue of $0.6M misses by $0.56M [3/29/2022 7:06 AM]	4.08	-0.61 (-13.09%)	4.40	-0.30 (-6.38%)	3.34 - 10.25	820,346	410,000	4,321
SCYNEXIS GAAP EPS of -$1.05 misses by $0.28, revenue of $0.6M misses by $0.56M [3/29/2022 7:06 AM] Scynexis stock fall 16% amid Q4 results [3/29/2022 12:27 PM] SCYNEXIS Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-29-22 07:00AM] Scynexis (SCYX) Reports Q4 Loss, Lags Revenue Estimates [Mar-29-22 08:15AM]
10-11-2021	PM	8:00 AM ET (Nov 10)	SCYX	SCYNEXIS, Inc.	130.72	-0.06	-0.79	-0.28	SCYNEXIS EPS beats by $0.67, beats on revenue [11/10/2021 7:38 AM]	5.67	0.07 (1.25%)	5.93	0.33 (5.89%)	4.90 - 10.25	228,818	140,000	11,388
SCYNEXIS Q3 2021 Earnings Preview [11/9/2021 11:23 AM] SCYNEXIS EPS beats by $0.67, beats on revenue [11/10/2021 7:38 AM] SCYNEXIS Announces Successful Completion of Phase 1 Trial Evaluating Intravenous (IV) Formulation of Ibrexafungerp [Nov-09-21 08:30AM] SCYNEXIS Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-10-21 07:34AM] Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 10:15AM]
17-05-2021	PM		SCYX	SCYNEXIS, Inc.	141.73	-0.23	0.00	-1.10	SCYNEXIS EPS beats by $0.35 [5/17/2021 9:00 AM]	8.02	0.91 (12.80%)	7.21	0.10 (1.41%)	4.20 - 10.15	387,966	280,000	1,604
SCYNEXIS EPS beats by $0.35 [5/17/2021 9:00 AM] SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank [May-14-21 08:30AM] SCYNEXIS Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-17-21 08:30AM]
29-03-2021	PM	8:45 AM ET (Mar 29)	SCYX	Scynexis, Inc.	89.00	-1.47	-0.78	0.00	SCYNEXIS EPS misses by $3.39 [3/29/2021 8:31 AM]	7.27	-0.38 (-4.97%)	7.94	0.29 (3.79%)	4.20 - 10.50	392,358	420,000	9,051
SCYNEXIS EPS misses by $3.39 [3/29/2021 8:31 AM] SCYNEXIS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-29-21 08:20AM]